NCT04894643 2026-03-20
PARC
EBG MedAustron GmbH
Phase NA Recruiting
Clinical Trials
18 trialsNCT02921022 2025-11-26
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT06539806 2024-08-06
Clinical Study Evaluating the Effect of Losartan
Tanta University
Phase NA Recruiting
NCT05903703 2023-06-15
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
First People's Hospital of Hangzhou
Phase NA Not yet recruiting
NCT01683422 2021-08-10
Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer
Loma Linda University
Phase NA Terminated
NCT01938716 2020-11-05
Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
M.D. Anderson Cancer Center
Phase NA Terminated
NCT03690323 2018-10-01
PELICAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Unknown
NCT01989000 2018-06-27
MIPA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT00763516 2017-09-06
PC02
University of Florida
Phase NA Completed
NCT00685763 2017-08-24
PC01
University of Florida
Phase NA Completed
NCT00448838 2016-12-15
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
University of Miami
Phase NA Completed
NCT02685228 2016-02-18
SLOWDOSE001
The First Hospital of Jilin University
Phase NA Unknown
NCT01411072 2014-10-03
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
AHS Cancer Control Alberta
Phase NA Unknown
NCT00159471 2014-05-22
Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.
University of Southern California
Phase NA Terminated
NCT00079365 2013-12-04
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
National Cancer Institute (NCI)
Phase NA Unknown
NCT01442974 2013-03-13
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
Grupo Hospital de Madrid
Phase NA Completed
NCT00003851 2013-02-15
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
Columbia University
Phase NA Terminated
NCT00524069 2013-02-01
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Roswell Park Cancer Institute
Phase NA Withdrawn